GLEN BURNIE, Md.--(BUSINESS WIRE)--NovaSom, Inc., the leader in obstructive sleep apnea (OSA) home testing and cost-containment solutions, announces the launch of its next generation MediTrack® cloud-based CRM application. The MediTrack OSA management platform is designed to enable custom processing of payer-specific medical policy, billing, utilization management and therapy coordination requirements to efficiently manage home sleep testing, OSA diagnosis and recommended therapy.
NovaSom’s proprietary MediTrack system allows physicians to order a NovaSom home sleep test online or by fax. The platform provides customizable information fields for easier physician entry of payer required data, leverages payer communication preferences, and incorporates payer-specific messaging into patient shipping and handling and device return logistics. The system also manages rapid upload of patient sleep data for interpretation by a Board Certified physician, and then promptly publishes the OSA study results for secure online and fax delivery to the ordering physician. Upon positive diagnosis, the MediTrack technology integrates assignment of payer-preferred therapy providers.
Richard Hassett, MD, CEO, NovaSom, Inc., said, “This significant technology investment allows NovaSom to provide a custom physician order workflow system that incorporates payer-specific medical policy, utilization management and therapy coordination. This end-to-end integration greatly reduces the administrative burden for physicians, payers and patients. The alignment with payer-designated therapy partners assures continuity between diagnosis and initiation of treatment.”
Home sleep testing with NovaSom is a less expensive, convenient and clinically proven alternative to in-facility sleep testing, and appropriate for up to 80% of the undiagnosed OSA patient population. NovaSom is fully accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center and CMS approved as an Independent Diagnostic Testing Facility.
For more information about MediTrack and NovaSom home sleep testing, please visit www.NovaSom.com.
About OSA
Obstructive Sleep Apnea (OSA) affects an estimated 18 million Americans. However, a startling 85 percent of sufferers are undiagnosed and untreated, generating significant clinical complications and medical expense for patients and the healthcare system. Nearly half of all OSA patients also suffer from one or more serious health condition such as diabetes, hypertension or heart failure that is either aggravated or caused by OSA. Treating OSA reduces medical expenses, improves patient quality of life and lowers associated health risks.
About NovaSom, Inc.
NovaSom, Inc. is the market leader in obstructive sleep apnea (OSA) home testing, with the first FDA-cleared system and more than 75,000 tests performed to date. It is the manufacturer of NovaSom® HST and second generation AccuSom® HST. Together with its proprietary cloud-based MediTrack® OSA management platform, NovaSom’s home sleep testing technology has been shown to provide in-home, clinically equivalent diagnosis of OSA at a significantly reduced cost compared to in-facility sleep testing. Through partnerships with major health insurers, the NovaSom HST is a covered benefit for over 165 million commercially insured lives in the U.S. as of January 1, 2012, and is also approved for Medicare patients.
NovaSom also offers comprehensive service programs that are utilized by payers and physicians nationwide, including its unique Payer Solutions Program that enables health insurers to realize significant cost saving by leveraging proven managed care utilization tools to redirect OSA testing to the home. NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center and is approved by CMS as an Independent Diagnostic Testing Facility. For more information, visit www.NovaSom.com.
Data on file with NovaSom, Inc